GCM
MDT icon

Gladius Capital Management’s Medtronic MDT Stock Holding History

Gladius Capital Management’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-1,100
Closed -$114K – 311
2021
Q4 		$114K Sell
1,100
-1,100
-50% -$127K 0.01% 236
2021
Q3 		$276K Hold
2,200
– – 0.02% 93
2021
Q2 		$274K Sell
2,200
-59,400
-96% -$7.46M 0.03% 97
2021
Q1 		$7.28M Buy
61,600
+5,900
+11% +$691K 0.27% 83
2020
Q4 		$6.53M Buy
55,700
+46,800
+526% +$5.15M 0.32% 83
2020
Q3 		$925K Buy
+8,900
New +$894K 0.09% 93
2020
Q2 		– Sell
-9,300
Closed -$839K – 82
2020
Q1 		$839K Sell
9,300
-1,300
-12% -$138K 0.09% 99
2019
Q4 		$1.2M Buy
10,600
+3,700
+54% +$406K 0.08% 125
2019
Q3 		$750K Buy
+6,900
New +$720K 0.03% 168

Other funds holding MDT

WA
WestEnd Advisors Charlotte, North Carolina $4.49B AUM 19.44% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Gladius Capital Management's MDT Position: Q1 2022 in Review

Gladius Capital Management sold out of Medtronic (MDT) in Q1 2022, closing a stake of 178 shares — an estimated $19K sold.

Gladius Capital Management first reported a position in MDT in Q4 2018 and held it in 10 quarters. The position peaked at $1.01M in Q1 2020. 2,101 funds tracked by Wall St. Rank hold MDT as of Q1 2022.

  • Gladius Capital Management reported no remaining Medtronic position as of Q1 2022 after selling out during the quarter.
  • Gladius Capital Management sold 178 Medtronic shares in Q1 2022, an estimated $19K.
  • Gladius Capital Management first reported a position in Medtronic in Q4 2018 and held it in 10 quarters.
  • Gladius Capital Management's Medtronic position peaked at $1.01M in Q1 2020.
  • 2,101 funds tracked by Wall St. Rank held Medtronic as of Q1 2022.

Based on Gladius Capital Management's 13F filing for Q1 2022, filed 29 Apr 2022.